SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.

Crawshaw, AF; Farah, Y; Deal, A; Rustage, K; Hayward, SE; Carter, J; Knights, F; Goldsmith, LP; Campos-Matos, I; Wurie, F; et al. Crawshaw, AF; Farah, Y; Deal, A; Rustage, K; Hayward, SE; Carter, J; Knights, F; Goldsmith, LP; Campos-Matos, I; Wurie, F; Majeed, A; Bedford, H; Forster, AS; Hargreaves, S (2022) Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis, 22 (9). e254-e266. ISSN 1474-4457 https://doi.org/10.1016/S1473-3099(22)00066-4
SGUL Authors: Hargreaves, Sally Goldsmith, Lucy Pollyanna

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (936kB)

Abstract

Understanding why some migrants in Europe are at risk of underimmunisation and show lower vaccination uptake for routine and COVID-19 vaccines is critical if we are to address vaccination inequities and meet the goals of WHO's new Immunisation Agenda 2030. We did a systematic review (PROSPERO: CRD42020219214) exploring barriers and facilitators of vaccine uptake (categorised using the 5As taxonomy: access, awareness, affordability, acceptance, activation) and sociodemographic determinants of undervaccination among migrants in the EU and European Economic Area, the UK, and Switzerland. We searched MEDLINE, CINAHL, and PsycINFO from 2000 to 2021 for primary research, with no restrictions on language. 5259 data sources were screened, with 67 studies included from 16 countries, representing 366 529 migrants. We identified multiple access barriers-including language, literacy, and communication barriers, practical and legal barriers to accessing and delivering vaccination services, and service barriers such as lack of specific guidelines and knowledge of health-care professionals-for key vaccines including measles-mumps-rubella, diphtheria-pertussis-tetanus, human papillomavirus, influenza, polio, and COVID-19 vaccines. Acceptance barriers were mostly reported in eastern European and Muslim migrants for human papillomavirus, measles, and influenza vaccines. We identified 23 significant determinants of undervaccination in migrants (p<0·05), including African origin, recent migration, and being a refugee or asylum seeker. We did not identify a strong overall association with gender or age. Tailored vaccination messaging, community outreach, and behavioural nudges facilitated uptake. Migrants' barriers to accessing health care are already well documented, and this Review confirms their role in limiting vaccine uptake. These findings hold immediate relevance to strengthening vaccination programmes in high-income countries, including for COVID-19, and suggest that tailored, culturally sensitive, and evidence-informed strategies, unambiguous public health messaging, and health system strengthening are needed to address access and acceptance barriers to vaccination in migrants and create opportunities and pathways for offering catch-up vaccinations to migrants.

Item Type: Article
Additional Information: © 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: Microbiology, 1103 Clinical Sciences, 1108 Medical Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Lancet Infect Dis
ISSN: 1474-4457
Language: eng
Dates:
DateEvent
24 August 2022Published
13 April 2022Published Online
26 January 2022Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
NIHR300072National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
SBF005\1111Academy of Medical Scienceshttp://dx.doi.org/10.13039/501100000691
MRC/N013638/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
NIHR300290National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
M775Rosetrees Trusthttp://dx.doi.org/10.13039/501100000833
PubMed ID: 35429463
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114317
Publisher's version: https://doi.org/10.1016/S1473-3099(22)00066-4

Actions (login required)

Edit Item Edit Item